open access

Vol 84, No 5 (2013)
ARTICLES
Get Citation

The use of venous ports in oncological patients

Klaudia Barwińska-Pobłocka, Dariusz Wydra, Anna Abacjew-Chmyłko, Anna Szkop-Dominiak
DOI: 10.17772/gp/1586
·
Ginekol Pol 2013;84(5).

open access

Vol 84, No 5 (2013)
ARTICLES

Abstract

Introduction: Venous ports provide a permanent, long-lasting and easy access to the central veins. These subcutaneously inserted systems have found application in the therapy of patients with oncological and chronic illnesses, and in treatment of children with hemophilia. During a planned continuous infusion of chemotherapy they increase patient comfort, reducing the risk of local inflammatory states and moderating the risk of spilling the cytostatic agent to the perivesical compartment. Material and methods: 83 patients with venous subcutaneous ports implanted between July 2006 and November 2011 were included into the study. The methods of implantation and usage were presented. Length of time the port is in situ and occurrence of early and late complications was evaluated. Results: The longest indwelling time for port was 1484 days, while the shortest was 70 days. In 89.9% of cases, the correct position of the port’s tip was noted during a control X-ray performed after the implantation. Early complications were not observed, while late ones concerned 16.86% of patients and included: generalized bacteriemia (8.43%), local inflammation of the skin and of the subcutaneous tissue (1.2%), venous thrombosis (2.41%), migration of the catheter (1.2%), necrosis of the skin over the port’s chamber (2.41%). Conclusion: Venous ports play an important role in the treatment of cancer patients. The placement of venous ports is a safe procedure that has a low rate of early complications. The frequency of late complications correlates with that described in the literature.

Abstract

Introduction: Venous ports provide a permanent, long-lasting and easy access to the central veins. These subcutaneously inserted systems have found application in the therapy of patients with oncological and chronic illnesses, and in treatment of children with hemophilia. During a planned continuous infusion of chemotherapy they increase patient comfort, reducing the risk of local inflammatory states and moderating the risk of spilling the cytostatic agent to the perivesical compartment. Material and methods: 83 patients with venous subcutaneous ports implanted between July 2006 and November 2011 were included into the study. The methods of implantation and usage were presented. Length of time the port is in situ and occurrence of early and late complications was evaluated. Results: The longest indwelling time for port was 1484 days, while the shortest was 70 days. In 89.9% of cases, the correct position of the port’s tip was noted during a control X-ray performed after the implantation. Early complications were not observed, while late ones concerned 16.86% of patients and included: generalized bacteriemia (8.43%), local inflammation of the skin and of the subcutaneous tissue (1.2%), venous thrombosis (2.41%), migration of the catheter (1.2%), necrosis of the skin over the port’s chamber (2.41%). Conclusion: Venous ports play an important role in the treatment of cancer patients. The placement of venous ports is a safe procedure that has a low rate of early complications. The frequency of late complications correlates with that described in the literature.
Get Citation

Keywords

venous port, chemotherapy, complications, infection

About this article
Title

The use of venous ports in oncological patients

Journal

Ginekologia Polska

Issue

Vol 84, No 5 (2013)

DOI

10.17772/gp/1586

Bibliographic record

Ginekol Pol 2013;84(5).

Keywords

venous port
chemotherapy
complications
infection

Authors

Klaudia Barwińska-Pobłocka
Dariusz Wydra
Anna Abacjew-Chmyłko
Anna Szkop-Dominiak

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl